Item 7.01. Regulation FD Disclosure.

On January 10, 2022, IN8bio, Inc. (the "Company") posted its Corporate Overview, dated January 2022, to the "News & Events" subsection of the "Investors" tab on the Company's website at www.in8bio.com.

The information provided in Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses